Inhibitory Antibodies
-
F1614 Anti-LEPR/CD295 Antibody (Mibavademab)Summary: Anti-LEPR/CD295 Antibody (Mibavademab) -
F1615 Anti-RHD/CD240d Antibody (Roledumab)Summary: Anti-RHD/CD240d Antibody (Roledumab) -
F1616 Anti-TNFRSF4/OX40/CD134 Antibody (Telazorlimab)Summary: Anti-TNFRSF4/OX40/CD134 Antibody (Telazorlimab) -
F1617 Anti-NKG2D/CD314 Antibody (Tesnatilimab)Summary: Anti-NKG2D/CD314 Antibody (Tesnatilimab) -
F1618 Anti-TNFRSF4/OX40/CD134 Antibody (Vonlerizumab)Summary: Anti-TNFRSF4/OX40/CD134 Antibody (Vonlerizumab) -
F1619 Anti-SCFR/c-Kit/CD117 Antibody (LOP628)Summary: Anti-SCFR/c-Kit/CD117 Antibody (LOP628) -
F1620 Anti-TNFRSF21/DR6/CD358 Antibody (Abbvie patent anti-TNFRSF21)Summary: Anti-TNFRSF21/DR6/CD358 Antibody (Abbvie patent anti-TNFRSF21) -
F1621 Anti-PTPRC/CD45 Antibody (Apamistamab)Summary: Anti-PTPRC/CD45 Antibody (Apamistamab) -
F1622 Anti-Syndecan-1/CD138 Antibody (Indatuximab)Summary: Anti-Syndecan-1/CD138 Antibody (Indatuximab) -
F1623 Anti-TCR Antibody (TOL101)Summary: Anti-TCR Antibody (TOL101)